• Accueil >
  • Publications >
  • Long-term clinical activity, safety and patient-reported quality of life for emactuzumab-treated patients with diffuse-type tenosynovial giant-cell tumour

Long-term clinical activity, safety and patient-reported quality of life for emactuzumab-treated patients with diffuse-type tenosynovial giant-cell tumour

1 déc. 2020European Journal of Cancer

DOI : 10.1016/j.ejca.2020.09.038

Auteurs

Philippe A. Cassier, Antoine Italiano, Carlos Gomez-Roca, Christophe Le Tourneau, Maud Toulmonde, Sandra P. D'Angelo, Kristy Weber, Delphine Loirat, Wolfgang Jacob, Anna-Maria Jegg, Francesca Michielin, Randolph Christen, Carl Watson, Michael Cannarile, Irina Klaman, Keelara Abiraj, Carola H. Ries, Martin Weisser, Dominik Rüttinger, Jean-Yves Blay, Jean-Pierre Delord